Breast cancer remains one of the most common and concerning health challenges for women worldwide. With increasing awareness and advancements in medical science, several options have emerged to reduce the risk of developing this disease. One such option is Raloxifene, a selective estrogen receptor modulator (SERM) that has shown promise in breast c